Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 6 of 6 clinical reviews.
Evidence-based guide to alprostadil dosing considerations for Black and African ancestry men, covering pharmacogenomics, cardiovascular comorbidities, and titration protocols.
Read clinical reviewEvidence-based guide to alprostadil dose modifications in East Asian men, covering pharmacogenomic differences, lower starting doses, BMI thresholds, and clinical monitoring protocols.
Read clinical reviewEvidence-based guide to alprostadil dosing in South Asian men, covering pharmacogenomic factors, cardiovascular considerations, and titration protocols specific to this population.
Read clinical reviewEvidence-based guide to alprostadil dosing considerations for Hispanic and Latino patients, covering pharmacogenomic variants, diabetes-related factors, and clinical titration protocols.
Read clinical reviewEvidence-based review of alprostadil efficacy in East Asian men, covering pharmacogenomic factors, dose-response data, BMI-adjusted dosing, and clinical considerations for Caverject and MUSE.
Read clinical reviewEvidence-based review of how alprostadil safety, dosing, and adverse-effect patterns differ in South Asian men, including cardiovascular considerations, pharmacogenomic data, and clinical monitoring recommendations.
Read clinical review